Saol Therapeutics Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Saol Therapeutics's estimated annual revenue is currently $9.2M per year.(i)
  • Saol Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Saol Therapeutics has 46 Employees.(i)
  • Saol Therapeutics grew their employee count by 2% last year.

Saol Therapeutics's People

NameTitleEmail/Phone
1
Head RegulatoryReveal Email/Phone
2
SVP, StrategyReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
VP, Operations & ComplianceReveal Email/Phone
5
QA and Regulatory Affairs DirectorReveal Email/Phone
6
Senior Director, Drug Product DevelopmentReveal Email/Phone
7
Medical DirectorReveal Email/Phone
8
Senior Director Strategic MarketingReveal Email/Phone
9
Senior Director Strategic MarketingReveal Email/Phone
10
General ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.5M1228%N/AN/A
#2
$10.7M53-17%N/AN/A
#3
$9.2M462%N/AN/A
#4
$24.1M1205%N/AN/A
#5
$7.2M36-20%N/AN/A
#6
$27.7M138-30%N/AN/A
#7
$39.8M19837%N/AN/A
#8
$0.5M525%$50MN/A
#9
$13.7M68-7%N/AN/A
#10
$10.3M5111%N/AN/A
Add Company

What Is Saol Therapeutics?

Saol Therapeutics (pronounced ?Sail??) is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases. The company has a strategic emphasis on the neurology therapeutic area. For more information, please visit our website: www.saolrx.com.

keywords:N/A

N/A

Total Funding

46

Number of Employees

$9.2M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Saol Therapeutics News

2022-04-20 - Amneal Scores Second US Biosimilar Approval With Avastin ...

Amneal says an $83.5m deal to acquire Saol Therapeutics' baclofen franchise will also bring the firm an “experienced institutional...

2022-03-22 - Saol Therapeutics and GeneDx, Inc. Collaborate to Detect ...

Saol is focused on clinical development activity in rare diseases, with a focus on mitochondrial disorders, as well as central nervous system...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.7M46-6%N/A
#2
$10.2M479%N/A
#3
$5.5M472%N/A
#4
$12.4M470%N/A
#5
$15M484%N/A